{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T22:33:46Z","timestamp":1794868426811,"version":"4.9.1"},"reference-count":160,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,10,26]],"date-time":"2022-10-26T00:00:00Z","timestamp":1666742400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,10,26]],"date-time":"2022-10-26T00:00:00Z","timestamp":1666742400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["F31AG074700"],"award-info":[{"award-number":["F31AG074700"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["T32AG071444"],"award-info":[{"award-number":["T32AG071444"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["AG061788"],"award-info":[{"award-number":["AG061788"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["K01AG049050"],"award-info":[{"award-number":["K01AG049050"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["R03 AG054936"],"award-info":[{"award-number":["R03 AG054936"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["P30 AG010133"],"award-info":[{"award-number":["P30 AG010133"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["P30 AG072976"],"award-info":[{"award-number":["P30 AG072976"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["R01 AG019771"],"award-info":[{"award-number":["R01 AG019771"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["R01 AG057739"],"award-info":[{"award-number":["R01 AG057739"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["U19 AG024904"],"award-info":[{"award-number":["U19 AG024904"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["R01 LM013463"],"award-info":[{"award-number":["R01 LM013463"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["R01 AG068193"],"award-info":[{"award-number":["R01 AG068193"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["T32 AG071444"],"award-info":[{"award-number":["T32 AG071444"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["U01 AG068057"],"award-info":[{"award-number":["U01 AG068057"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["U01 AG072177"],"award-info":[{"award-number":["U01 AG072177"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000092","name":"U.S. National Library of Medicine","doi-asserted-by":"publisher","award":["R01 LM012535"],"award-info":[{"award-number":["R01 LM012535"]}],"id":[{"id":"10.13039\/100000092","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl Neurodegener"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>This literature review investigates the significant overlap between myelin-repair signaling pathways and pathways known to contribute to hallmark pathologies of Alzheimer\u2019s disease (AD). We discuss previously investigated therapeutic targets of amyloid, tau, and ApoE, as well as other potential therapeutic targets that have been empirically shown to contribute to both remyelination and progression of AD. Current evidence shows that there are multiple AD-relevant pathways which overlap significantly with remyelination and myelin repair through the encouragement of oligodendrocyte proliferation, maturation, and myelin production. There is a present need for a single, cohesive model of myelin homeostasis in AD. While determining a causative pathway is beyond the scope of this review, it may be possible to investigate the pathological overlap of myelin repair and AD through therapeutic approaches.<\/jats:p>","DOI":"10.1186\/s40035-022-00321-1","type":"journal-article","created":{"date-parts":[[2022,10,25]],"date-time":"2022-10-25T23:38:35Z","timestamp":1666741115000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":41,"title":["Myelin repair in Alzheimer\u2019s disease: a review of biological pathways and potential therapeutics"],"prefix":"10.1186","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8348-0139","authenticated-orcid":false,"given":"Lauren Rose","family":"Hirschfeld","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shannon L.","family":"Risacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwangsik","family":"Nho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"Saykin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,10,26]]},"reference":[{"issue":"1","key":"321_CR1","volume":"8","author":"J Fessel","year":"2022","unstructured":"Fessel J. Reversing Alzheimer\u2019s disease dementia with clemastine, fingolimod, or rolipram, plus anti-amyloid therapy. Alzheimers Dement. 2022;8(1): e12242.","journal-title":"Alzheimers Dement"},{"issue":"8","key":"321_CR2","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1016\/j.jalz.2018.03.007","volume":"14","author":"M Bouhrara","year":"2018","unstructured":"Bouhrara M, Reiter DA, Bergeron CM, Zukley LM, Ferrucci L, Resnick SM, et al. Evidence of demyelination in mild cognitive impairment and dementia using a direct and specific magnetic resonance imaging measure of myelin content. Alzheimers Dement. 2018;14(8):998\u20131004.","journal-title":"Alzheimers Dement"},{"issue":"1","key":"321_CR3","doi-asserted-by":"publisher","first-page":"71","DOI":"10.3233\/BPL-160033","volume":"2","author":"AL MacKay","year":"2016","unstructured":"MacKay AL, Laule C. Magnetic resonance of myelin water: an in vivo marker for myelin. Brain Plast. 2016;2(1):71\u201391.","journal-title":"Brain Plast"},{"issue":"5","key":"321_CR4","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1002\/jmri.25849","volume":"47","author":"E Kavroulakis","year":"2018","unstructured":"Kavroulakis E, Simos PG, Kalaitzakis G, Maris TG, Karageorgou D, Zaganas I, et al. Myelin content changes in probable Alzheimer\u2019s disease and mild cognitive impairment: associations with age and severity of neuropsychiatric impairment. J Magn Reson Imaging. 2018;47(5):1359\u201372.","journal-title":"J Magn Reson Imaging"},{"issue":"3","key":"321_CR5","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1111\/jon.12960","volume":"32","author":"M Park","year":"2022","unstructured":"Park M, Lee HP, Kim J, Kim DH, Moon Y, Moon WJ. Brain myelin water fraction is associated with APOE4 allele status in patients with cognitive impairment. J Neuroimaging. 2022;32(3):521\u20139.","journal-title":"J Neuroimaging"},{"issue":"1","key":"321_CR6","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1001\/jamaneurol.2016.3232","volume":"74","author":"DC Dean III","year":"2017","unstructured":"Dean DC III, Hurley SA, Kecskemeti SR, O\u2019Grady JP, Canda C, Davenport-Sis NJ, et al. Association of amyloid pathology with myelin alteration in preclinical Alzheimer disease. JAMA Neurol. 2017;74(1):41\u20139.","journal-title":"JAMA Neurol"},{"issue":"7","key":"321_CR7","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/j.neurobiolaging.2003.09.005","volume":"25","author":"G Bartzokis","year":"2004","unstructured":"Bartzokis G, Sultzer D, Lu PH, Nuechterlein KH, Mintz J, Cummings JL. Heterogeneous age-related breakdown of white matter structural integrity: implications for cortical \u201cdisconnection\u201d in aging and Alzheimer\u2019s disease. Neurobiol Aging. 2004;25(7):843\u201351.","journal-title":"Neurobiol Aging"},{"issue":"2","key":"321_CR8","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.jalz.2007.01.019","volume":"3","author":"G Bartzokis","year":"2007","unstructured":"Bartzokis G, Lu PH, Mintz J. Human brain myelination and amyloid beta deposition in Alzheimer\u2019s disease. Alzheimers Dement. 2007;3(2):122\u20135.","journal-title":"Alzheimers Dement"},{"issue":"8","key":"321_CR9","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1016\/j.neurobiolaging.2009.08.007","volume":"32","author":"G Bartzokis","year":"2011","unstructured":"Bartzokis G. Alzheimer\u2019s disease as homeostatic responses to age-related myelin breakdown. Neurobiol Aging. 2011;32(8):1341\u201371.","journal-title":"Neurobiol Aging"},{"issue":"1","key":"321_CR10","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s40478-018-0515-3","volume":"6","author":"SE Nasrabady","year":"2018","unstructured":"Nasrabady SE, Rizvi B, Goldman JE, Brickman AM. White matter changes in Alzheimer\u2019s disease: a focus on myelin and oligodendrocytes. Acta Neuropathol Commun. 2018;6(1):22.","journal-title":"Acta Neuropathol Commun"},{"issue":"2","key":"321_CR11","doi-asserted-by":"publisher","first-page":"345","DOI":"10.5114\/aoms.2018.76863","volume":"16","author":"E Papu\u0107","year":"2018","unstructured":"Papu\u0107 E, Rejdak K. The role of myelin damage in Alzheimer\u2019s disease pathology. Arch Med Sci. 2018;16(2):345\u201351.","journal-title":"Arch Med Sci"},{"issue":"21","key":"321_CR12","doi-asserted-by":"publisher","first-page":"30003","DOI":"10.18632\/oncotarget.8981","volume":"7","author":"J Sun","year":"2016","unstructured":"Sun J, Zhou H, Bai F, Ren Q, Zhang Z. Myelin injury induces axonal transport impairment but not AD-like pathology in the hippocampus of cuprizone-fed mice. Oncotarget. 2016;7(21):30003.","journal-title":"Oncotarget"},{"key":"321_CR13","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.neurobiolaging.2019.10.003","volume":"85","author":"M Bouhrara","year":"2020","unstructured":"Bouhrara M, Rejimon AC, Cortina LE, Khattar N, Bergeron CM, Ferrucci L, et al. Adult brain aging investigated using BMC-mcDESPOT\u2013based myelin water fraction imaging. Neurobiol Aging. 2020;85:131\u20139.","journal-title":"Neurobiol Aging"},{"issue":"1","key":"321_CR14","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.neurobiolaging.2003.08.001","volume":"25","author":"G Bartzokis","year":"2004","unstructured":"Bartzokis G. Quadratic trajectories of brain myelin content: unifying construct for neuropsychiatric disorders. Neurobiol Aging. 2004;25(1):49\u201362.","journal-title":"Neurobiol Aging"},{"key":"321_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroimage.2022.118988","volume":"251","author":"C Triebswetter","year":"2022","unstructured":"Triebswetter C, Kiely M, Khattar N, Ferrucci L, Resnick SM, Spencer RG, et al. Differential associations between apolipoprotein E alleles and cerebral myelin content in normative aging. Neuroimage. 2022;251: 118988.","journal-title":"Neuroimage"},{"issue":"2","key":"321_CR16","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1002\/glia.22432","volume":"61","author":"G Behrendt","year":"2013","unstructured":"Behrendt G, Baer K, Buffo A, Curtis MA, Faull RL, Rees MI, et al. Dynamic changes in myelin aberrations and oligodendrocyte generation in chronic amyloidosis in mice and men. Glia. 2013;61(2):273\u201386.","journal-title":"Glia"},{"issue":"6","key":"321_CR17","doi-asserted-by":"publisher","DOI":"10.1111\/acel.13380","volume":"20","author":"J Zhang","year":"2021","unstructured":"Zhang J, Wu N, Wang S, Yao Z, Xiao F, Lu J, et al. Neuronal loss and microgliosis are restricted to the core of A\u03b2 deposits in mouse models of Alzheimer\u2019s disease. Aging Cell. 2021;20(6): e13380.","journal-title":"Aging Cell"},{"issue":"3","key":"321_CR18","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.neurobiolaging.2010.05.007","volume":"33","author":"M Horiuchi","year":"2012","unstructured":"Horiuchi M, Maezawa I, Itoh A, Wakayama K, Jin L-W, Itoh T, et al. Amyloid \u03b21\u201342 oligomer inhibits myelin sheet formation in vitro. Neurobiol Aging. 2012;33(3):499\u2013509.","journal-title":"Neurobiol Aging"},{"issue":"6","key":"321_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41419-019-1636-8","volume":"10","author":"T Quintela-L\u00f3pez","year":"2019","unstructured":"Quintela-L\u00f3pez T, Ortiz-Sanz C, Serrano-Regal MP, Gaminde-Blasco A, Valero J, Baleriola J, et al. A\u03b2 oligomers promote oligodendrocyte differentiation and maturation via integrin \u03b21 and Fyn kinase signaling. Cell Death Dis. 2019;10(6):1\u201316.","journal-title":"Cell Death Dis"},{"issue":"1","key":"321_CR20","doi-asserted-by":"publisher","first-page":"175","DOI":"10.3233\/JAD-150694","volume":"50","author":"A Ezra","year":"2016","unstructured":"Ezra A, Rabinovich-Nikitin I, Rabinovich-Toidman P, Solomon B. Multifunctional effect of human serum albumin reduces Alzheimer\u2019s disease related pathologies in the 3xTg mouse model. J Alzheimers Dis. 2016;50(1):175\u201388.","journal-title":"J Alzheimers Dis"},{"issue":"2","key":"321_CR21","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1111\/j.1471-4159.2007.04828.x","volume":"103","author":"CE Fleming","year":"2007","unstructured":"Fleming CE, Saraiva MJ, Sousa MM. Transthyretin enhances nerve regeneration. J Neurochem. 2007;103(2):831\u20139.","journal-title":"J Neurochem"},{"issue":"4","key":"321_CR22","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1002\/glia.23562","volume":"67","author":"GA McCanney","year":"2019","unstructured":"McCanney GA, McGrath MA, Otto TD, Burchmore R, Yates EA, Bavington CD, et al. Low sulfated heparins target multiple proteins for central nervous system repair. Glia. 2019;67(4):668\u201387.","journal-title":"Glia"},{"issue":"3","key":"321_CR23","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1002\/glia.23561","volume":"67","author":"PH Truong","year":"2019","unstructured":"Truong PH, Ciccotosto GD, Merson TD, Spoerri L, Chuei MJ, Ayers M, et al. Amyloid precursor protein and amyloid precursor-like protein 2 have distinct roles in modulating myelination, demyelination, and remyelination of axons. Glia. 2019;67(3):525\u201338.","journal-title":"Glia"},{"key":"321_CR24","doi-asserted-by":"publisher","first-page":"628156","DOI":"10.3389\/fimmu.2021.628156","volume":"12","author":"C Ma","year":"2021","unstructured":"Ma C, Hunt JB, Kovalenko A, Liang H, Selenica M-LB, Orr MB, et al. Myeloid arginase 1 insufficiency exacerbates amyloid-\u03b2 associated neurodegenerative pathways and glial signatures in a mouse model of Alzheimer\u2019s disease: a targeted transcriptome analysis. Front Immunol. 2021;12:628156.","journal-title":"Front Immunol"},{"key":"321_CR25","doi-asserted-by":"publisher","first-page":"57","DOI":"10.3389\/fnmol.2018.00057","volume":"11","author":"KD Bruce","year":"2018","unstructured":"Bruce KD, Gorkhali S, Given K, Coates AM, Boyle KE, Macklin WB, et al. Lipoprotein lipase is a feature of alternatively-activated microglia and may facilitate lipid uptake in the CNS during demyelination. Front Mol Neurosci. 2018;11:57.","journal-title":"Front Mol Neurosci"},{"issue":"1","key":"321_CR26","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1101\/gad.1039703","volume":"17","author":"DF Seals","year":"2003","unstructured":"Seals DF, Courtneidge SA. The ADAMs family of metalloproteases: multidomain proteins with multiple functions. Genes Dev. 2003;17(1):7\u201330.","journal-title":"Genes Dev"},{"key":"321_CR27","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.nbd.2017.09.008","volume":"109","author":"G Llufriu-Dab\u00e9n","year":"2018","unstructured":"Llufriu-Dab\u00e9n G, Carrete A, Chierto E, Mailleux J, Camand E, Simon A, et al. Targeting demyelination via \u03b1-secretases promoting sAPP\u03b1 release to enhance remyelination in central nervous system. Neurobiol Dis. 2018;109:11\u201324.","journal-title":"Neurobiol Dis"},{"issue":"1","key":"321_CR28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41398-019-0665-5","volume":"10","author":"B Ray","year":"2020","unstructured":"Ray B, Maloney B, Sambamurti K, Karnati HK, Nelson PT, Greig NH, et al. Rivastigmine modifies the \u03b1-secretase pathway and potentially early Alzheimer\u2019s disease. Transl Psychiatry. 2020;10(1):1\u201317.","journal-title":"Transl Psychiatry"},{"issue":"11","key":"321_CR29","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1038\/s41401-018-0206-4","volume":"40","author":"X Cui","year":"2019","unstructured":"Cui X, Guo YE, Fang JH, Shi CJ, Suo N, Zhang R, et al. Donepezil, a drug for Alzheimer\u2019s disease, promotes oligodendrocyte generation and remyelination. Acta Pharmacol Sin. 2019;40(11):1386\u201393.","journal-title":"Acta Pharmacol Sin"},{"issue":"5440","key":"321_CR30","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1126\/science.286.5440.735","volume":"286","author":"R Vassar","year":"1999","unstructured":"Vassar R, Bennett BD, Babu-Khan S, Kahn S, Mendiaz EA, Denis P, et al. \u03b2-Secretase cleavage of Alzheimer\u2019s amyloid precursor protein by the transmembrane aspartic protease BACE. Science. 1999;286(5440):735\u201341.","journal-title":"Science"},{"issue":"12","key":"321_CR31","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.1038\/nn1797","volume":"9","author":"X Hu","year":"2006","unstructured":"Hu X, Hicks CW, He W, Wong P, Macklin WB, Trapp BD, et al. Bace1 modulates myelination in the central and peripheral nervous system. Nat Neurosci. 2006;9(12):1520\u20135.","journal-title":"Nat Neurosci"},{"key":"321_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.pneurobio.2019.101643","volume":"180","author":"H Kataria","year":"2019","unstructured":"Kataria H, Alizadeh A, Karimi-Abdolrezaee S. Neuregulin-1\/ErbB network: an emerging modulator of nervous system injury and repair. Prog Neurobiol. 2019;180: 101643.","journal-title":"Prog Neurobiol"},{"issue":"1","key":"321_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40478-018-0603-4","volume":"6","author":"T-VV Nguyen","year":"2018","unstructured":"Nguyen T-VV, Hayes M, Zbesko JC, Frye JB, Congrove NR, Belichenko NP, et al. Alzheimer\u2019s associated amyloid and tau deposition co-localizes with a homeostatic myelin repair pathway in two mouse models of post-stroke mixed dementia. Acta Neuropathol Commun. 2018;6(1):1\u201325.","journal-title":"Acta Neuropathol Commun"},{"issue":"8","key":"321_CR34","doi-asserted-by":"publisher","first-page":"2970","DOI":"10.1096\/fj.08-106666","volume":"22","author":"X Hu","year":"2008","unstructured":"Hu X, He W, Diaconu C, Tang X, Kidd GJ, Macklin WB, et al. Genetic deletion of BACE1 in mice affects remyelination of sciatic nerves. FASEB J. 2008;22(8):2970\u201380.","journal-title":"FASEB J"},{"issue":"9","key":"321_CR35","doi-asserted-by":"publisher","first-page":"3806","DOI":"10.1523\/JNEUROSCI.5207-14.2015","volume":"35","author":"X Hu","year":"2015","unstructured":"Hu X, Hu J, Dai L, Trapp B, Yan R. Axonal and Schwann cell BACE1 is equally required for remyelination of peripheral nerves. J Neurosci. 2015;35(9):3806\u201314.","journal-title":"J Neurosci"},{"issue":"27","key":"321_CR36","doi-asserted-by":"publisher","first-page":"23967","DOI":"10.1074\/jbc.M111.251538","volume":"286","author":"X Luo","year":"2011","unstructured":"Luo X, Prior M, He W, Hu X, Tang X, Shen W, et al. Cleavage of neuregulin-1 by BACE1 or ADAM10 protein produces differential effects on myelination. J Biol Chem. 2011;286(27):23967\u201374.","journal-title":"J Biol Chem"},{"issue":"5","key":"321_CR37","doi-asserted-by":"publisher","first-page":"1868","DOI":"10.1096\/fj.12-224212","volume":"27","author":"X Hu","year":"2013","unstructured":"Hu X, Schlanger R, He W, Macklin WB, Yan R. Reversing hypomyelination in BACE1-null mice with Akt-DD overexpression. FASEB J. 2013;27(5):1868\u201373.","journal-title":"FASEB J"},{"issue":"5","key":"321_CR38","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/j.neuron.2010.08.018","volume":"67","author":"MZ Kounnas","year":"2010","unstructured":"Kounnas MZ, Danks AM, Cheng S, Tyree C, Ackerman E, Zhang X, et al. Modulation of \u03b3-secretase reduces \u03b2-amyloid deposition in a transgenic mouse model of Alzheimer\u2019s disease. Neuron. 2010;67(5):769\u201380.","journal-title":"Neuron"},{"issue":"1","key":"321_CR39","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1046\/j.1471-4159.2001.00012.x","volume":"76","author":"H Dovey","year":"2001","unstructured":"Dovey H, John V, Anderson J, Chen L, de Saint AP, Fang L, et al. Functional gamma-secretase inhibitors reduce beta-amyloid peptide levels in brain. J Neurochem. 2001;76(1):173\u201381.","journal-title":"J Neurochem"},{"issue":"6","key":"321_CR40","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1016\/j.stemcr.2018.10.022","volume":"11","author":"T Okubo","year":"2018","unstructured":"Okubo T, Nagoshi N, Kohyama J, Tsuji O, Shinozaki M, Shibata S, et al. Treatment with a gamma-secretase inhibitor promotes functional recovery in human iPSC-derived transplants for chronic spinal cord injury. Stem Cell Rep. 2018;11(6):1416\u201332.","journal-title":"Stem Cell Rep"},{"issue":"1\u20132","key":"321_CR41","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.jns.2007.09.007","volume":"265","author":"M Jurynczyk","year":"2008","unstructured":"Jurynczyk M, Jurewicz A, Bielecki B, Raine CS, Selmaj K. Overcoming failure to repair demyelination in EAE: \u03b3-secretase inhibition of Notch signaling. J Neurol Sci. 2008;265(1\u20132):5\u201311.","journal-title":"J Neurol Sci"},{"issue":"2","key":"321_CR42","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0087227","volume":"9","author":"J McQueen","year":"2014","unstructured":"McQueen J, Reimer MM, Holland PR, Manso Y, McLaughlin M, Fowler JH, et al. Restoration of oligodendrocyte pools in a mouse model of chronic cerebral hypoperfusion. PLoS One. 2014;9(2): e87227.","journal-title":"PLoS ONE"},{"issue":"1","key":"321_CR43","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1002\/glia.20734","volume":"57","author":"MK Desai","year":"2009","unstructured":"Desai MK, Sudol KL, Janelsins MC, Mastrangelo MA, Frazer ME, Bowers WJ. Triple-transgenic Alzheimer\u2019s disease mice exhibit region-specific abnormalities in brain myelination patterns prior to appearance of amyloid and tau pathology. Glia. 2009;57(1):54\u201365.","journal-title":"Glia"},{"issue":"1","key":"321_CR44","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1046\/j.0305-1846.2003.00510.x","volume":"30","author":"J Tian","year":"2004","unstructured":"Tian J, Shi J, Bailey K, Mann D. Relationships between arteriosclerosis, cerebral amyloid angiopathy and myelin loss from cerebral cortical white matter in Alzheimer\u2019s disease. Neuropathol Appl Neurobiol. 2004;30(1):46\u201356.","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"1","key":"321_CR45","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1111\/jnc.14999","volume":"154","author":"I Kaya","year":"2020","unstructured":"Kaya I, Jennische E, Lange S, Tarik Baykal A, Malmberg P, Fletcher JS. Brain region-specific amyloid plaque-associated myelin lipid loss, APOE deposition and disruption of the myelin sheath in familial Alzheimer\u2019s disease mice. J Neurochem. 2020;154(1):84\u201398.","journal-title":"J Neurochem"},{"issue":"2","key":"321_CR46","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/j.apsb.2021.10.002","volume":"12","author":"BR Troutwine","year":"2021","unstructured":"Troutwine BR, Hamid L, Lysaker CR, Strope TA, Wilkins HM. Apolipoprotein E and Alzheimer\u2019s disease. Acta Pharm Sin B. 2021;12(2):496\u2013510.","journal-title":"Acta Pharm Sin B"},{"issue":"2","key":"321_CR47","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/S0022-510X(98)00118-X","volume":"158","author":"O Gaillard","year":"1998","unstructured":"Gaillard O, Gervais A, Meillet D, Plassart E, Fontaine B, Lyon-Caen O, et al. Apolipoprotein E and multiple sclerosis: a biochemical and genetic investigation. J Neurol Sci. 1998;158(2):180\u20136.","journal-title":"J Neurol Sci"},{"issue":"1\u20132","key":"321_CR48","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.jns.2012.05.050","volume":"320","author":"M Rafiei","year":"2012","unstructured":"Rafiei M, Yeganeh MZ, Sheikholeslami S, Gozalpour E, Ghaffarpour M, Hedayati M. Apolipoprotein E polymorphisms status in Iranian patients with multiple sclerosis. J Neurol Sci. 2012;320(1\u20132):22\u20135.","journal-title":"J Neurol Sci"},{"issue":"2","key":"321_CR49","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1016\/j.neuroimage.2010.08.052","volume":"54","author":"L Ryan","year":"2011","unstructured":"Ryan L, Walther K, Bendlin BB, Lue LF, Walker DG, Glisky EL. Age-related differences in white matter integrity and cognitive function are related to APOE status. Neuroimage. 2011;54(2):1565\u201377.","journal-title":"Neuroimage"},{"key":"321_CR50","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroimage.2020.117243","volume":"222","author":"J Remer","year":"2020","unstructured":"Remer J, Dean DC III, Chen K, Reiman RA, Huentelman MJ, Reiman EM, et al. Longitudinal white matter and cognitive development in pediatric carriers of the apolipoprotein \u03b54 allele. Neuroimage. 2020;222: 117243.","journal-title":"Neuroimage"},{"issue":"5","key":"321_CR51","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1093\/jnen\/59.5.361","volume":"59","author":"C Carlin","year":"2000","unstructured":"Carlin C, Murray L, Graham D, Doyle D, Nicoll J. Involvement of apolipoprotein E in multiple sclerosis: absence of remyelination associated with possession of the APOE \u03b52 allele. J Neuropathol Exp Neurol. 2000;59(5):361\u20137.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"2","key":"321_CR52","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1038\/ng0694-180","volume":"7","author":"E Corder","year":"1994","unstructured":"Corder E, Saunders AM, Risch N, Strittmatter W, Schmechel D, Gaskell P, et al. Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease. Nat Genet. 1994;7(2):180\u20134.","journal-title":"Nat Genet"},{"issue":"10","key":"321_CR53","doi-asserted-by":"publisher","first-page":"2878","DOI":"10.1016\/j.neubiorev.2013.10.010","volume":"37","author":"S Suri","year":"2013","unstructured":"Suri S, Heise V, Trachtenberg AJ, Mackay CE. The forgotten APOE allele: a review of the evidence and suggested mechanisms for the protective effect of APOE \u025b2. Neurosci Biobehav Rev. 2013;37(10):2878\u201386.","journal-title":"Neurosci Biobehav Rev"},{"issue":"5","key":"321_CR54","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1191\/1352458503ms950oa","volume":"9","author":"D Karussis","year":"2003","unstructured":"Karussis D, Michaelson D, Grigoriadis N, Korezyn A, Mizrachi-Koll R, Chapman S, et al. Lack of apolipoprotein-E exacerbates experimental allergic encephalomyelitis. Mult Scler J. 2003;9(5):476\u201380.","journal-title":"Mult Scler J"},{"issue":"6376","key":"321_CR55","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1126\/science.aan4183","volume":"359","author":"L Cantuti-Castelvetri","year":"2018","unstructured":"Cantuti-Castelvetri L, Fitzner D, Bosch-Queralt M, Weil MT, Su M, Sen P, et al. Defective cholesterol clearance limits remyelination in the aged central nervous system. Science. 2018;359(6376):684\u20138.","journal-title":"Science"},{"issue":"6","key":"321_CR56","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1002\/biof.1187","volume":"40","author":"S Wang","year":"2014","unstructured":"Wang S, Smith JD. ABCA1 and nascent HDL biogenesis. BioFactors. 2014;40(6):547\u201354.","journal-title":"BioFactors"},{"issue":"2","key":"321_CR57","doi-asserted-by":"publisher","first-page":"149","DOI":"10.2119\/molmed.2011.00183","volume":"18","author":"G-J Zhao","year":"2012","unstructured":"Zhao G-J, Yin K, Fu Y-C, Tang C-K. The interaction of ApoA-I and ABCA1 triggers signal transduction pathways to mediate efflux of cellular lipids. Mol Med. 2012;18(2):149\u201358.","journal-title":"Mol Med"},{"issue":"9","key":"321_CR58","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1016\/S0022-2275(20)30266-2","volume":"42","author":"S Santamarina-Fojo","year":"2001","unstructured":"Santamarina-Fojo S, Remaley AT, Neufeld EB, Brewer HB. Regulation and intracellular trafficking of the ABCA1 transporter. J Lipid Res. 2001;42(9):1339\u201345.","journal-title":"J Lipid Res"},{"issue":"39","key":"321_CR59","doi-asserted-by":"publisher","first-page":"41197","DOI":"10.1074\/jbc.M407962200","volume":"279","author":"V Hirsch-Reinshagen","year":"2004","unstructured":"Hirsch-Reinshagen V, Zhou S, Burgess BL, Bernier L, McIsaac SA, Chan JY, et al. Deficiency of ABCA1 impairs apolipoprotein E metabolism in brain. J Biol Chem. 2004;279(39):41197\u2013207.","journal-title":"J Biol Chem"},{"issue":"2","key":"321_CR60","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1097\/00041433-200104000-00006","volume":"12","author":"G Schmitz","year":"2001","unstructured":"Schmitz G, Langmann T. Structure, function and regulation of the ABC1 gene product. Curr Opin Lipidol. 2001;12(2):129\u201340.","journal-title":"Curr Opin Lipidol"},{"issue":"12","key":"321_CR61","doi-asserted-by":"publisher","first-page":"4369","DOI":"10.3390\/ijms21124369","volume":"21","author":"L Li","year":"2020","unstructured":"Li L, Li R, Zacharek A, Wang F, Landschoot-Ward J, Chopp M, et al. ABCA1\/APOE\/HDL signaling pathway facilitates myelination and oligodendrogenesis after stroke. Int J Mol Sci. 2020;21(12):4369.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"321_CR62","doi-asserted-by":"publisher","first-page":"81","DOI":"10.3390\/ijms20010081","volume":"20","author":"CM Wolfe","year":"2018","unstructured":"Wolfe CM, Fitz NF, Nam KN, Lefterov I, Koldamova R. The role of APOE and TREM2 in Alzheimer\u2032 s disease\u2014current understanding and perspectives. Int J Mol Sci. 2018;20(1):81.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"321_CR63","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1056\/NEJMoa1211851","volume":"368","author":"R Guerreiro","year":"2013","unstructured":"Guerreiro R, Wojtas A, Bras J, Carrasquillo M, Rogaeva E, Majounie E, et al. TREM2 variants in Alzheimer\u2019s disease. N Engl J Med. 2013;368(2):117\u201327.","journal-title":"N Engl J Med"},{"issue":"1","key":"321_CR64","doi-asserted-by":"publisher","first-page":"199","DOI":"10.3233\/JAD-160663","volume":"55","author":"AA Raha","year":"2017","unstructured":"Raha AA, Henderson JW, Stott SR, Vuono R, Foscarin S, Friedland RP, et al. Neuroprotective effect of TREM-2 in aging and Alzheimer\u2019s disease model. J Alzheimers Dis. 2017;55(1):199\u2013217.","journal-title":"J Alzheimers Dis"},{"issue":"10","key":"321_CR65","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20210227","volume":"218","author":"G Gouna","year":"2021","unstructured":"Gouna G, Klose C, Bosch-Queralt M, Liu L, Gokce O, Schifferer M, et al. TREM2-dependent lipid droplet biogenesis in phagocytes is required for remyelination. J Exp Med. 2021;218(10): e20210227.","journal-title":"J Exp Med"},{"issue":"4","key":"321_CR66","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0040124","volume":"4","author":"K Takahashi","year":"2007","unstructured":"Takahashi K, Prinz M, Stagi M, Chechneva O, Neumann H. TREM2-transduced myeloid precursors mediate nervous tissue debris clearance and facilitate recovery in an animal model of multiple sclerosis. PLoS Med. 2007;4(4): e124.","journal-title":"PLoS Med"},{"issue":"12","key":"321_CR67","doi-asserted-by":"publisher","first-page":"2104","DOI":"10.1002\/glia.23043","volume":"64","author":"F Petkovi\u0107","year":"2016","unstructured":"Petkovi\u0107 F, Campbell IL, Gonzalez B, Castellano B. Astrocyte-targeted production of interleukin-6 reduces astroglial and microglial activation in the cuprizone demyelination model: Implications for myelin clearance and oligodendrocyte maturation. Glia. 2016;64(12):2104\u201319.","journal-title":"Glia"},{"issue":"7","key":"321_CR68","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1016\/j.neuron.2021.01.027","volume":"109","author":"S Safaiyan","year":"2021","unstructured":"Safaiyan S, Besson-Girard S, Kaya T, Cantuti-Castelvetri L, Liu L, Ji H, et al. White matter aging drives microglial diversity. Neuron. 2021;109(7):1100\u201317.","journal-title":"Neuron"},{"issue":"7","key":"321_CR69","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1016\/j.cell.2017.05.018","volume":"169","author":"H Keren-Shaul","year":"2017","unstructured":"Keren-Shaul H, Spinrad A, Weiner A, Matcovitch-Natan O, Dvir-Szternfeld R, Ulland TK, et al. A unique microglia type associated with restricting development of Alzheimer\u2019s disease. Cell. 2017;169(7):1276-90.e17.","journal-title":"Cell"},{"issue":"2","key":"321_CR70","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1002\/(SICI)1096-8628(19990416)88:2<136::AID-AJMG8>3.0.CO;2-D","volume":"88","author":"L Baum","year":"1999","unstructured":"Baum L, Chen L, Masliah E, Chan YS, Ng HK, Pang CP. Lipoprotein lipase mutations and Alzheimer\u2019s disease. Am J Med Genet. 1999;88(2):136\u20139.","journal-title":"Am J Med Genet"},{"issue":"2","key":"321_CR71","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1111\/jnc.15170","volume":"159","author":"S Pedrini","year":"2021","unstructured":"Pedrini S, Chatterjee P, Hone E, Martins RN. High-density lipoprotein-related cholesterol metabolism in Alzheimer\u2019s disease. J Neurochem. 2021;159(2):343\u201377.","journal-title":"J Neurochem"},{"issue":"5","key":"321_CR72","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1111\/j.1460-9568.2006.05007.x","volume":"24","author":"JF Blain","year":"2006","unstructured":"Blain JF, Aumont N, Th\u00e9roux L, Dea D, Poirier J. A polymorphism in lipoprotein lipase affects the severity of Alzheimer\u2019s disease pathophysiology. Eur J Neurosci. 2006;24(5):1245\u201351.","journal-title":"Eur J Neurosci"},{"issue":"2","key":"321_CR73","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1002\/glia.23540","volume":"67","author":"VSB Wies Mancini","year":"2019","unstructured":"Wies Mancini VSB, Pasquini JM, Correale JD, Pasquini LA. Microglial modulation through colony-stimulating factor-1 receptor inhibition attenuates demyelination. Glia. 2019;67(2):291\u2013308.","journal-title":"Glia"},{"issue":"1","key":"321_CR74","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1002\/jnr.22743","volume":"90","author":"K Nelissen","year":"2012","unstructured":"Nelissen K, Mulder M, Smets I, Timmermans S, Smeets K, Ameloot M, et al. Liver X receptors regulate cholesterol homeostasis in oligodendrocytes. J Neurosci Res. 2012;90(1):60\u201371.","journal-title":"J Neurosci Res"},{"key":"321_CR75","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2021.135764","volume":"750","author":"DF Santos-Gil","year":"2021","unstructured":"Santos-Gil DF, Arboleda G, Sandoval-Hern\u00e1ndez AG. Retinoid X receptor activation promotes re-myelination in a very old triple transgenic mouse model of Alzheimer\u2019s disease. Neurosci Lett. 2021;750: 135764.","journal-title":"Neurosci Lett"},{"issue":"1","key":"321_CR76","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1124\/jpet.110.167882","volume":"334","author":"F-Q Li","year":"2010","unstructured":"Li F-Q, Fowler KA, Neil JE, Colton CA, Vitek MP. An apolipoprotein E-mimetic stimulates axonal regeneration and remyelination after peripheral nerve injury. J Pharmacol Exp Ther. 2010;334(1):106\u201315.","journal-title":"J Pharmacol Exp Ther"},{"issue":"8","key":"321_CR77","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1242\/jcs.040717","volume":"122","author":"A Gaultier","year":"2009","unstructured":"Gaultier A, Wu X, Le Moan N, Takimoto S, Mukandala G, Akassoglou K, et al. Low-density lipoprotein receptor-related protein 1 is an essential receptor for myelin phagocytosis. J Cell Sci. 2009;122(8):1155\u201362.","journal-title":"J Cell Sci"},{"issue":"1","key":"321_CR78","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s42003-021-02984-4","volume":"5","author":"S Song","year":"2022","unstructured":"Song S, Yu L, Hasan MN, Paruchuri SS, Mullett SJ, Sullivan ML, et al. Elevated microglial oxidative phosphorylation and phagocytosis stimulate post-stroke brain remodeling and cognitive function recovery in mice. Commun Biol. 2022;5(1):1\u201315.","journal-title":"Commun Biol"},{"issue":"4","key":"321_CR79","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1002\/glia.23286","volume":"66","author":"J Jackson","year":"2018","unstructured":"Jackson J, Bianco G, Rosa AO, Cowan K, Bond P, Anichtchik O, et al. White matter tauopathy: transient functional loss and novel myelin remodeling. Glia. 2018;66(4):813\u201327.","journal-title":"Glia"},{"issue":"3","key":"321_CR80","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1002\/glia.22940","volume":"64","author":"B Ossola","year":"2016","unstructured":"Ossola B, Zhao C, Compston A, Pluchino S, Franklin RJ, Spillantini MG. Neuronal expression of pathological tau accelerates oligodendrocyte progenitor cell differentiation. Glia. 2016;64(3):457\u201371.","journal-title":"Glia"},{"issue":"1","key":"321_CR81","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.neuint.2011.10.011","volume":"60","author":"C Fressinaud","year":"2012","unstructured":"Fressinaud C, Berges R, Eyer J. Axon cytoskeleton proteins specifically modulate oligodendrocyte growth and differentiation in vitro. Neurochem Int. 2012;60(1):78\u201390.","journal-title":"Neurochem Int"},{"issue":"2","key":"321_CR82","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1111\/j.1471-4159.2008.05600.x","volume":"107","author":"A Belkadi","year":"2008","unstructured":"Belkadi A, LoPresti P. Truncated Tau with the Fyn-binding domain and without the microtubule-binding domain hinders the myelinating capacity of an oligodendrocyte cell line. J Neurochem. 2008;107(2):351\u201360.","journal-title":"J Neurochem"},{"issue":"9","key":"321_CR83","doi-asserted-by":"publisher","first-page":"2304","DOI":"10.1523\/JNEUROSCI.4162-03.2004","volume":"24","author":"G Lee","year":"2004","unstructured":"Lee G, Thangavel R, Sharma VM, Litersky JM, Bhaskar K, Fang SM, et al. Phosphorylation of tau by fyn: implications for Alzheimer\u2019s disease. J Neurosci. 2004;24(9):2304\u201312.","journal-title":"J Neurosci"},{"issue":"8","key":"321_CR84","first-page":"395","volume":"75","author":"Y Fu","year":"2020","unstructured":"Fu Y, Yang Y, Shi J, Bishayee K, Lin L, Lin Y, et al. Acori tatarinowii rhizoma extract ameliorates Alzheimer\u2019s pathological syndromes by repairing myelin injury and lowering Tau phosphorylation in mice. Pharmazie. 2020;75(8):395\u2013400.","journal-title":"Pharmazie"},{"issue":"1","key":"321_CR85","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.expneurol.2012.06.010","volume":"237","author":"S Hochmeister","year":"2012","unstructured":"Hochmeister S, Romauch M, Bauer J, Seifert-Held T, Weissert R, Linington C, et al. Re-expression of N-cadherin in remyelinating lesions of experimental inflammatory demyelination. Exp Neurol. 2012;237(1):70\u20137.","journal-title":"Exp Neurol"},{"key":"321_CR86","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.lfs.2017.05.010","volume":"180","author":"SQ Liu","year":"2017","unstructured":"Liu SQ, Zhang ML, Zhang HJ, Liu FZ, Chu RJ, Zhang GX, et al. Matrine promotes oligodendrocyte development in CNS autoimmunity through the PI3K\/Akt signaling pathway. Life Sci. 2017;180:36\u201341.","journal-title":"Life Sci"},{"issue":"2","key":"321_CR87","first-page":"404","volume":"17","author":"BM Kopec","year":"2019","unstructured":"Kopec BM, Kiptoo P, Zhao L, Rosa-Molinar E, Siahaan TJ. Noninvasive brain delivery and efficacy of BDNF to stimulate neuroregeneration and suppression of disease relapse in EAE mice. Mol Pharm. 2019;17(2):404\u201316.","journal-title":"Mol Pharm"},{"issue":"7","key":"321_CR88","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s13205-021-02900-x","volume":"11","author":"G Qin","year":"2021","unstructured":"Qin G, Wang Y, Liu Z, Mana L, Huang S, Wang P. Shenzhiling oral solution promotes myelin repair through PI3K\/Akt-mTOR pathway in STZ-induced SAD mice. 3 Biotech. 2021;11(7):1\u201315.","journal-title":"3 Biotech"},{"issue":"2","key":"321_CR89","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1111\/jnc.13856","volume":"140","author":"O Imamura","year":"2017","unstructured":"Imamura O, Arai M, Dateki M, Takishima K. Donepezil promotes differentiation of neural stem cells into mature oligodendrocytes at the expense of astrogenesis. J Neurochem. 2017;140(2):231\u201344.","journal-title":"J Neurochem"},{"key":"321_CR90","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2021.112436","volume":"145","author":"A Rivera","year":"2022","unstructured":"Rivera A, Pieropan F, Williams G, Calzolari F, Butt A, Azim K. Drug connectivity mapping and functional analysis reveal therapeutic small molecules that differentially modulate myelination. Biomed Pharmacother. 2022;145: 112436.","journal-title":"Biomed Pharmacother"},{"key":"321_CR91","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.733945","volume":"9","author":"YY Xie","year":"2021","unstructured":"Xie YY, Pan TT, Xu DE, Huang X, Tang Y, Huang W, et al. Clemastine ameliorates myelin deficits via preventing senescence of oligodendrocytes precursor cells in Alzheimer\u2019s disease model mouse. Front Cell Dev Biol. 2021;9:733945.","journal-title":"Front Cell Dev Biol"},{"issue":"14","key":"321_CR92","doi-asserted-by":"publisher","first-page":"2292","DOI":"10.1016\/j.neuron.2021.05.012","volume":"109","author":"J-F Chen","year":"2021","unstructured":"Chen J-F, Liu K, Hu B, Li R-R, Xin W, Chen H, et al. Enhancing myelin renewal reverses cognitive dysfunction in a murine model of Alzheimer\u2019s disease. Neuron. 2021;109(14):2292\u2013307.","journal-title":"Neuron"},{"issue":"5","key":"321_CR93","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1038\/s41593-019-0372-9","volume":"22","author":"P Zhang","year":"2019","unstructured":"Zhang P, Kishimoto Y, Grammatikakis I, Gottimukkala K, Cutler RG, Zhang S, et al. Senolytic therapy alleviates A\u03b2-associated oligodendrocyte progenitor cell senescence and cognitive deficits in an Alzheimer\u2019s disease model. Nat Neurosci. 2019;22(5):719\u201328.","journal-title":"Nat Neurosci"},{"issue":"3","key":"321_CR94","doi-asserted-by":"publisher","DOI":"10.1111\/acel.13333","volume":"20","author":"J Wang","year":"2021","unstructured":"Wang J, Liu B, Xu Y, Yang M, Wang C, Song M, et al. Activation of CREB-mediated autophagy by thioperamide ameliorates \u03b2-amyloid pathology and cognition in Alzheimer\u2019s disease. Aging Cell. 2021;20(3): e13333.","journal-title":"Aging Cell"},{"key":"321_CR95","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmc.2021.116462","volume":"50","author":"M Falkenstein","year":"2021","unstructured":"Falkenstein M, Reiner-Link D, Zivkovic A, Gering I, Willbold D, Stark H. Histamine H3 receptor antagonists with peptidomimetic (keto) piperazine structures to inhibit A\u03b2 oligomerisation. Bioorg Med Chem. 2021;50: 116462.","journal-title":"Bioorg Med Chem"},{"key":"321_CR96","doi-asserted-by":"publisher","first-page":"709","DOI":"10.3389\/fphar.2017.00709","volume":"8","author":"A Alachkar","year":"2017","unstructured":"Alachkar A, \u0141a\u017cewska D, Kie\u0107-Kononowicz K, Sadek B. The histamine H3 receptor antagonist E159 reverses memory deficits induced by dizocilpine in passive avoidance and novel object recognition paradigm in rats. Front Pharmacol. 2017;8:709.","journal-title":"Front Pharmacol"},{"issue":"12","key":"321_CR97","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0189380","volume":"12","author":"Y Chen","year":"2017","unstructured":"Chen Y, Zhen W, Guo T, Zhao Y, Liu A, Rubio JP, et al. Histamine receptor 3 negatively regulates oligodendrocyte differentiation and remyelination. PLoS One. 2017;12(12): e0189380.","journal-title":"PLoS ONE"},{"issue":"2","key":"321_CR98","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/S1084-9521(02)00179-9","volume":"14","author":"M Baron","year":"2003","unstructured":"Baron M. An overview of the notch signalling pathway. Semin Cell Dev Biol. 2003;14(2):113\u20139.","journal-title":"Semin Cell Dev Biol"},{"key":"321_CR99","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.semcdb.2020.12.011","volume":"116","author":"A Kapoor","year":"2021","unstructured":"Kapoor A, Nation DA. Role of notch signaling in neurovascular aging and Alzheimer\u2019s disease. Semin Cell Dev Biol. 2021;116:90\u20137.","journal-title":"Semin Cell Dev Biol"},{"issue":"10111","key":"321_CR100","doi-asserted-by":"publisher","first-page":"2481","DOI":"10.1016\/S0140-6736(17)32346-2","volume":"390","author":"AJ Green","year":"2017","unstructured":"Green AJ, Gelfand JM, Cree BA, Bevan C, Boscardin WJ, Mei F, et al. Clemastine fumarate as a remyelinating therapy for multiple sclerosis (ReBUILD): a randomised, controlled, double-blind, crossover trial. Lancet. 2017;390(10111):2481\u20139.","journal-title":"Lancet"},{"issue":"3","key":"321_CR101","doi-asserted-by":"publisher","first-page":"e2115082119","DOI":"10.1073\/pnas.2115082119","volume":"119","author":"MH Park","year":"2022","unstructured":"Park MH, Park KH, Choi BJ, Han WH, Yoon HJ, Jung HY, et al. Discovery of a dual-action small molecule that improves neuropathological features of Alzheimer\u2019s disease mice. Proc Natl Acad Sci U S A. 2022;119(3):e2115082119.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"321_CR102","doi-asserted-by":"publisher","first-page":"e0178622","DOI":"10.1371\/journal.pone.0178622","volume":"12","author":"M Chami","year":"2017","unstructured":"Chami M, Halmer R, Schnoeder L, Anne Becker K, Meier C, Fassbender K, et al. Acid sphingomyelinase deficiency enhances myelin repair after acute and chronic demyelination. PLoS ONE. 2017;12(6):e0178622.","journal-title":"PLoS ONE"},{"key":"321_CR103","doi-asserted-by":"publisher","first-page":"331","DOI":"10.3389\/fphys.2014.00331","volume":"5","author":"N Beckmann","year":"2014","unstructured":"Beckmann N, Sharma D, Gulbins E, Becker KA, Edelmann B. Inhibition of acid sphingomyelinase by tricyclic antidepressants and analogons. Front Physiol. 2014;5:331.","journal-title":"Front Physiol"},{"key":"321_CR104","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2021.113895","volume":"347","author":"J Zhang","year":"2022","unstructured":"Zhang J, Buller BA, Zhang ZG, Zhang Y, Lu M, Rosene DL, et al. Exosomes derived from bone marrow mesenchymal stromal cells promote remyelination and reduce neuroinflammation in the demyelinating central nervous system. Exp Neurol. 2022;347: 113895.","journal-title":"Exp Neurol"},{"issue":"1","key":"321_CR105","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.febslet.2014.11.027","volume":"589","author":"K Yuyama","year":"2015","unstructured":"Yuyama K, Sun H, Usuki S, Sakai S, Hanamatsu H, Mioka T, et al. A potential function for neuronal exosomes: sequestering intracerebral amyloid-\u03b2 peptide. FEBS Lett. 2015;589(1):84\u20138.","journal-title":"FEBS Lett"},{"issue":"14","key":"321_CR106","doi-asserted-by":"publisher","first-page":"10977","DOI":"10.1074\/jbc.M111.324616","volume":"287","author":"K Yuyama","year":"2012","unstructured":"Yuyama K, Sun H, Mitsutake S, Igarashi Y. Sphingolipid-modulated exosome secretion promotes clearance of amyloid-\u03b2 by microglia. J Biol Chem. 2012;287(14):10977\u201389.","journal-title":"J Biol Chem"},{"issue":"1","key":"321_CR107","doi-asserted-by":"publisher","first-page":"59","DOI":"10.3233\/JAD-160599","volume":"55","author":"PP Sainaghi","year":"2017","unstructured":"Sainaghi PP, Bellan M, Lombino F, Alciato F, Carecchio M, Galimberti D, et al. Growth arrest specific 6 concentration is increased in the cerebrospinal fluid of patients with Alzheimer\u2019s disease. J Alzheimers Dis. 2017;55(1):59\u201365.","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"321_CR108","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12974-022-02397-y","volume":"19","author":"LD Owlett","year":"2022","unstructured":"Owlett LD, Karaahmet B, Le L, Belcher EK, Dionisio-Santos D, Olschowka JA, et al. Gas6 induces inflammation and reduces plaque burden but worsens behavior in a sex-dependent manner in the APP\/PS1 model of Alzheimer\u2019s disease. J Neuroinflamm. 2022;19(1):1\u201317.","journal-title":"J Neuroinflamm"},{"issue":"12","key":"321_CR109","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0015748","volume":"5","author":"V Tsiperson","year":"2010","unstructured":"Tsiperson V, Li X, Schwartz GJ, Raine CS, Shafit-Zagardo B. GAS6 enhances repair following cuprizone-induced demyelination. PLoS ONE. 2010;5(12): e15748.","journal-title":"PLoS ONE"},{"issue":"5","key":"321_CR110","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1038\/s41590-021-00913-5","volume":"22","author":"Y Huang","year":"2021","unstructured":"Huang Y, Happonen KE, Burrola PG, O\u2019Connor C, Hah N, Huang L, et al. Microglia use TAM receptors to detect and engulf amyloid \u03b2 plaques. Nat Immunol. 2021;22(5):586\u201394.","journal-title":"Nat Immunol"},{"issue":"6655","key":"321_CR111","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/36285","volume":"390","author":"M Kuro-o","year":"1997","unstructured":"Kuro-o M, Matsumura Y, Aizawa H, Kawaguchi H, Suga T, Utsugi T, et al. Mutation of the mouse klotho gene leads to a syndrome resembling ageing. Nature. 1997;390(6655):45\u201351.","journal-title":"Nature"},{"issue":"6","key":"321_CR112","doi-asserted-by":"publisher","first-page":"2358","DOI":"10.1523\/JNEUROSCI.5791-12.2015","volume":"35","author":"DB Dubal","year":"2015","unstructured":"Dubal DB, Zhu L, Sanchez PE, Worden K, Broestl L, Johnson E, et al. Life extension factor klotho prevents mortality and enhances cognition in hAPP transgenic mice. J Neurosci. 2015;35(6):2358\u201371.","journal-title":"J Neurosci"},{"issue":"1","key":"321_CR113","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-021-23755-z","volume":"12","author":"J Neitzel","year":"2021","unstructured":"Neitzel J, Franzmeier N, Rubinski A, Dichgans M, Brendel M, Malik R, et al. KL-VS heterozygosity is associated with lower amyloid-dependent tau accumulation and memory impairment in Alzheimer\u2019s disease. Nat Commun. 2021;12(1):1\u201312.","journal-title":"Nat Commun"},{"key":"321_CR114","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.neurobiolaging.2021.01.008","volume":"101","author":"ME Belloy","year":"2021","unstructured":"Belloy ME, Eger SJ, Le Guen Y, Napolioni V, Deters KD, Yang H-S, et al. KL\u2217 VS heterozygosity reduces brain amyloid in asymptomatic at-risk APOE\u2217 4 carriers. Neurobiol Aging. 2021;101:123\u20139.","journal-title":"Neurobiol Aging"},{"issue":"2","key":"321_CR115","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/s12031-015-0598-2","volume":"57","author":"E Zeldich","year":"2015","unstructured":"Zeldich E, Chen C-D, Avila R, Medicetty S, Abraham CR. The anti-aging protein Klotho enhances remyelination following cuprizone-induced demyelination. J Mol Neurosci. 2015;57(2):185\u201396.","journal-title":"J Mol Neurosci"},{"issue":"1","key":"321_CR116","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1007\/s12031-014-0336-1","volume":"55","author":"C-D Chen","year":"2015","unstructured":"Chen C-D, Li H, Liang J, Hixson K, Zeldich E, Abraham CR. The anti-aging and tumor suppressor protein Klotho enhances differentiation of a human oligodendrocytic hybrid cell line. J Mol Neurosci. 2015;55(1):76\u201390.","journal-title":"J Mol Neurosci"},{"issue":"5","key":"321_CR117","doi-asserted-by":"publisher","first-page":"1927","DOI":"10.1523\/JNEUROSCI.2080-12.2013","volume":"33","author":"C-D Chen","year":"2013","unstructured":"Chen C-D, Sloane JA, Li H, Aytan N, Giannaris EL, Zeldich E, et al. The antiaging protein Klotho enhances oligodendrocyte maturation and myelination of the CNS. J Neurosci. 2013;33(5):1927\u201339.","journal-title":"J Neurosci"},{"issue":"2","key":"321_CR118","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/s12031-017-1011-0","volume":"64","author":"C-D Chen","year":"2018","unstructured":"Chen C-D, Zeldich E, Li Y, Yuste A, Abraham CR. Activation of the anti-aging and cognition-enhancing gene klotho by CRISPR-dCas9 transcriptional effector complex. J Mol Neurosci. 2018;64(2):175\u201384.","journal-title":"J Mol Neurosci"},{"issue":"4","key":"321_CR119","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1177\/0960327120960775","volume":"40","author":"M Ibrahim","year":"2021","unstructured":"Ibrahim M, Haleem M, AbdelWahab S, Abdel-Aziz A. Sildenafil ameliorates Alzheimer disease via the modulation of vascular endothelial growth factor and vascular cell adhesion molecule-1 in rats. Hum Exp Toxicol. 2021;40(4):596\u2013607.","journal-title":"Hum Exp Toxicol"},{"issue":"4","key":"321_CR120","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1007\/s00401-010-0795-6","volume":"121","author":"P Pifarre","year":"2011","unstructured":"Pifarre P, Prado J, Baltrons MA, Giralt M, Gabarro P, Feinstein DL, et al. Sildenafil (Viagra) ameliorates clinical symptoms and neuropathology in a mouse model of multiple sclerosis. Acta Neuropathol. 2011;121(4):499\u2013508.","journal-title":"Acta Neuropathol"},{"key":"321_CR121","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.expneurol.2013.10.021","volume":"251","author":"P Pifarr\u00e9","year":"2014","unstructured":"Pifarr\u00e9 P, Gutierrez-Mecinas M, Prado J, Usero L, Roura-Mir C, Giralt M, et al. Phosphodiesterase 5 inhibition at disease onset prevents experimental autoimmune encephalomyelitis progression through immunoregulatory and neuroprotective actions. Exp Neurol. 2014;251:58\u201371.","journal-title":"Exp Neurol"},{"issue":"2","key":"321_CR122","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/j.cyto.2012.06.011","volume":"60","author":"AK de Santana Nunes","year":"2012","unstructured":"de Santana Nunes AK, Rap\u00f4so C, de Almeida Luna RL, da Cruz-H\u00f6fling MA, Peixoto CA. Sildenafil (Viagra\u00ae) down regulates cytokines and prevents demyelination in a cuprizone-induced MS mouse model. Cytokine. 2012;60(2):540\u201351.","journal-title":"Cytokine"},{"key":"321_CR123","doi-asserted-by":"publisher","first-page":"175909141983244","DOI":"10.1177\/1759091419832444","volume":"11","author":"J Mu\u00f1oz-Esquivel","year":"2019","unstructured":"Mu\u00f1oz-Esquivel J, G\u00f6ttle P, Aguirre-Cruz L, Flores-Rivera J, Corona T, Reyes-Ter\u00e1n G, et al. Sildenafil inhibits myelin expression and myelination of oligodendroglial precursor cells. ASN Neuro. 2019;11:1759091419832444.","journal-title":"ASN Neuro"},{"key":"321_CR124","first-page":"17","volume":"15","author":"Y Chang","year":"2021","unstructured":"Chang Y, Yao Y, Ma R, Wang Z, Hu J, Wu Y, et al. Dl-3-n-butylphthalide reduces cognitive deficits and alleviates neuropathology in P301S tau transgenic mice. Front Neurosci. 2021;15:17.","journal-title":"Front Neurosci"},{"key":"321_CR125","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.brainres.2019.03.017","volume":"1717","author":"X Cheng","year":"2019","unstructured":"Cheng X, Wang H, Liu C, Zhong S, Niu X, Zhang X, et al. Dl-3-n-butylphthalide promotes remyelination process in cerebral white matter in rats subjected to ischemic stroke. Brain Res. 2019;1717:167\u201375.","journal-title":"Brain Res"},{"issue":"29","key":"321_CR126","doi-asserted-by":"publisher","first-page":"7435","DOI":"10.1523\/JNEUROSCI.0727-08.2008","volume":"28","author":"V Pernet","year":"2008","unstructured":"Pernet V, Joly S, Christ F, Dimou L, Schwab ME. Nogo-A and myelin-associated glycoprotein differently regulate oligodendrocyte maturation and myelin formation. J Neurosci. 2008;28(29):7435\u201344.","journal-title":"J Neurosci"},{"issue":"1","key":"321_CR127","doi-asserted-by":"publisher","first-page":"25796","DOI":"10.3402\/pba.v5.25796","volume":"5","author":"R de Laat","year":"2015","unstructured":"de Laat R, Meabon JS, Wiley JC, Hudson MP, Montine TJ, Bothwell M. LINGO-1 promotes lysosomal degradation of amyloid-\u03b2 protein precursor. Pathobiol Aging Age Relat Dis. 2015;5(1):25796.","journal-title":"Pathobiol Aging Age Relat Dis"},{"issue":"41","key":"321_CR128","doi-asserted-by":"publisher","first-page":"25800","DOI":"10.1073\/pnas.2008762117","volume":"117","author":"S-F Lau","year":"2020","unstructured":"Lau S-F, Cao H, Fu AK, Ip NY. Single-nucleus transcriptome analysis reveals dysregulation of angiogenic endothelial cells and neuroprotective glia in Alzheimer\u2019s disease. Proc Natl Acad Sci U S A. 2020;117(41):25800\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"321_CR129","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.expneurol.2015.02.006","volume":"266","author":"Y Zhang","year":"2015","unstructured":"Zhang Y, Zhang YP, Pepinsky B, Huang G, Shields LB, Shields CB, et al. Inhibition of LINGO-1 promotes functional recovery after experimental spinal cord demyelination. Exp Neurol. 2015;266:68\u201373.","journal-title":"Exp Neurol"},{"issue":"10","key":"321_CR130","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.1016\/j.biocel.2008.03.018","volume":"40","author":"S Mi","year":"2008","unstructured":"Mi S, Sandrock A, Miller RH. LINGO-1 and its role in CNS repair. Int J Biochem Cell Biol. 2008;40(10):1971\u20138.","journal-title":"Int J Biochem Cell Biol"},{"key":"321_CR131","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.neubiorev.2015.06.009","volume":"56","author":"JL Andrews","year":"2015","unstructured":"Andrews JL, Fernandez-Enright F. A decade from discovery to therapy: Lingo-1, the dark horse in neurological and psychiatric disorders. Neurosci Biobehav Rev. 2015;56:97\u2013114.","journal-title":"Neurosci Biobehav Rev"},{"issue":"5","key":"321_CR132","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1111\/cns.12809","volume":"24","author":"D Wu","year":"2018","unstructured":"Wu D, Tang X, Gu LH, Li XL, Qi XY, Bai F, et al. LINGO-1 antibody ameliorates myelin impairment and spatial memory deficits in the early stage of 5 XFAD mice. CNS Neurosci Ther. 2018;24(5):381\u201393.","journal-title":"CNS Neurosci Ther"},{"issue":"10","key":"321_CR133","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1002\/cne.25299","volume":"530","author":"H Yang","year":"2022","unstructured":"Yang H, Jiang L, Zhang Y, Liang X, Tang J, He Q, et al. Anti-LINGO-1 antibody treatment alleviates cognitive deficits and promotes maturation of oligodendrocytes in the hippocampus of APP\/PS1 mice. J Comp Neurol. 2022;530(10):1606\u201321.","journal-title":"J Comp Neurol"},{"issue":"7761","key":"321_CR134","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1038\/s41586-019-1195-2","volume":"570","author":"H Mathys","year":"2019","unstructured":"Mathys H, Davila-Velderrain J, Peng Z, Gao F, Mohammadi S, Young JZ, et al. Single-cell transcriptomic analysis of Alzheimer\u2019s disease. Nature. 2019;570(7761):332\u20137.","journal-title":"Nature"},{"issue":"35","key":"321_CR135","doi-asserted-by":"publisher","first-page":"12162","DOI":"10.1523\/JNEUROSCI.2127-15.2015","volume":"35","author":"K Kuboyama","year":"2015","unstructured":"Kuboyama K, Fujikawa A, Suzuki R, Noda M. Inactivation of protein tyrosine phosphatase receptor type Z by pleiotrophin promotes remyelination through activation of differentiation of oligodendrocyte precursor cells. J Neurosci. 2015;35(35):12162\u201371.","journal-title":"J Neurosci"},{"issue":"45","key":"321_CR136","doi-asserted-by":"publisher","first-page":"30879","DOI":"10.1074\/jbc.M802976200","volume":"283","author":"JPH Chow","year":"2008","unstructured":"Chow JPH, Fujikawa A, Shimizu H, Suzuki R, Noda M. Metalloproteinase-and \u03b3-secretase-mediated cleavage of protein-tyrosine phosphatase receptor type Z. J Biol Chem. 2008;283(45):30879\u201389.","journal-title":"J Biol Chem"},{"key":"321_CR137","doi-asserted-by":"publisher","first-page":"838692","DOI":"10.3389\/fnhum.2022.838692","volume":"16","author":"D Tran","year":"2022","unstructured":"Tran D, DiGiacomo P, Born DE, Georgiadis M, Zeineh M. Iron and Alzheimer\u2019s disease: from pathology to imaging. Front Hum Neurosci. 2022;16:838692.","journal-title":"Front Hum Neurosci"},{"issue":"1","key":"321_CR138","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1007\/s13311-020-00954-y","volume":"18","author":"A Gleason","year":"2021","unstructured":"Gleason A, Bush AI. Iron and ferroptosis as therapeutic targets in Alzheimer\u2019s disease. Neurotherapeutics. 2021;18(1):252\u201364.","journal-title":"Neurotherapeutics"},{"issue":"22","key":"321_CR139","doi-asserted-by":"publisher","first-page":"12442","DOI":"10.3390\/ijms222212442","volume":"22","author":"Y Peng","year":"2021","unstructured":"Peng Y, Chang X, Lang M. Iron homeostasis disorder and Alzheimer\u2019s disease. Int J Mol Sci. 2021;22(22):12442.","journal-title":"Int J Mol Sci"},{"key":"321_CR140","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroimage.2021.118267","volume":"239","author":"N Khattar","year":"2021","unstructured":"Khattar N, Triebswetter C, Kiely M, Ferrucci L, Resnick SM, Spencer RG, et al. Investigation of the association between cerebral iron content and myelin content in normative aging using quantitative magnetic resonance neuroimaging. Neuroimage. 2021;239: 118267.","journal-title":"Neuroimage"},{"issue":"6","key":"321_CR141","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.tins.2019.03.009","volume":"42","author":"HE M\u00f6ller","year":"2019","unstructured":"M\u00f6ller HE, Bossoni L, Connor JR, Crichton RR, Does MD, Ward RJ, et al. Iron, myelin, and the brain: neuroimaging meets neurobiology. Trends Neurosci. 2019;42(6):384\u2013401.","journal-title":"Trends Neurosci"},{"issue":"5","key":"321_CR142","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1093\/brain\/awaa089","volume":"143","author":"N Spotorno","year":"2020","unstructured":"Spotorno N, Acosta-Cabronero J, Stomrud E, Lampinen B, Strandberg OT, van Westen D, et al. Relationship between cortical iron and tau aggregation in Alzheimer\u2019s disease. Brain. 2020;143(5):1341\u20139.","journal-title":"Brain"},{"issue":"16","key":"321_CR143","doi-asserted-by":"publisher","first-page":"5374","DOI":"10.1523\/JNEUROSCI.3517-11.2012","volume":"32","author":"DL Schonberg","year":"2012","unstructured":"Schonberg DL, Goldstein EZ, Sahinkaya FR, Wei P, Popovich PG, McTigue DM. Ferritin stimulates oligodendrocyte genesis in the adult spinal cord and can be transferred from macrophages to NG2 cells in vivo. J Neurosci. 2012;32(16):5374\u201384.","journal-title":"J Neurosci"},{"issue":"8","key":"321_CR144","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1002\/glia.20416","volume":"54","author":"X Zhang","year":"2006","unstructured":"Zhang X, Surguladze N, Slagle-Webb B, Cozzi A, Connor JR. Cellular iron status influences the functional relationship between microglia and oligodendrocytes. Glia. 2006;54(8):795\u2013804.","journal-title":"Glia"},{"issue":"6","key":"321_CR145","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1111\/j.1471-4159.2008.05678.x","volume":"107","author":"B Todorich","year":"2008","unstructured":"Todorich B, Zhang X, Slagle-Webb B, Seaman WE, Connor JR. Tim-2 is the receptor for H-ferritin on oligodendrocytes. J Neurochem. 2008;107(6):1495\u2013505.","journal-title":"J Neurochem"},{"issue":"40","key":"321_CR146","doi-asserted-by":"publisher","first-page":"7609","DOI":"10.1523\/JNEUROSCI.1281-20.2020","volume":"40","author":"R Wan","year":"2020","unstructured":"Wan R, Cheli VT, Santiago-Gonz\u00e1lez DA, Rosenblum SL, Wan Q, Paez PM. Impaired postnatal myelination in a conditional knockout mouse for the ferritin heavy chain in oligodendroglial cells. J Neurosci. 2020;40(40):7609\u201324.","journal-title":"J Neurosci"},{"issue":"43","key":"321_CR147","doi-asserted-by":"publisher","first-page":"9142","DOI":"10.1523\/JNEUROSCI.1447-18.2018","volume":"38","author":"VT Cheli","year":"2018","unstructured":"Cheli VT, Gonz\u00e1lez DAS, Marziali LN, Zamora NN, Guitart ME, Spreuer V, et al. The divalent metal transporter 1 (DMT1) is required for iron uptake and normal development of oligodendrocyte progenitor cells. J Neurosci. 2018;38(43):9142\u201359.","journal-title":"J Neurosci"},{"issue":"12","key":"321_CR148","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0114174","volume":"9","author":"BX Wong","year":"2014","unstructured":"Wong BX, Tsatsanis A, Lim LQ, Adlard PA, Bush AI, Duce JA. \u03b2-Amyloid precursor protein does not possess ferroxidase activity but does stabilize the cell surface ferrous iron exporter ferroportin. PLoS ONE. 2014;9(12): e114174.","journal-title":"PLoS ONE"},{"issue":"14","key":"321_CR149","doi-asserted-by":"publisher","first-page":"4841","DOI":"10.1523\/JNEUROSCI.5328-11.2012","volume":"32","author":"K Schulz","year":"2012","unstructured":"Schulz K, Kroner A, David S. Iron efflux from astrocytes plays a role in remyelination. J Neurosci. 2012;32(14):4841\u20137.","journal-title":"J Neurosci"},{"issue":"12","key":"321_CR150","doi-asserted-by":"publisher","first-page":"4207","DOI":"10.1096\/fj.09-135749","volume":"23","author":"W Zheng","year":"2009","unstructured":"Zheng W, Xin N, Chi ZH, Zhao BL, Zhang J, Li JY, et al. Divalent metal transporter 1 is involved in amyloid precursor protein processing and A\u03b2 generation. FASEB J. 2009;23(12):4207\u201317.","journal-title":"FASEB J"},{"key":"321_CR151","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.jinorgbio.2016.06.022","volume":"162","author":"A Jahshan","year":"2016","unstructured":"Jahshan A, Esteves-Villanueva JO, Martic-Milne S. Evaluation of ferritin and transferrin binding to tau protein. J Inorg Biochem. 2016;162:127\u201334.","journal-title":"J Inorg Biochem"},{"issue":"9","key":"321_CR152","doi-asserted-by":"publisher","first-page":"616","DOI":"10.3390\/metabo11090616","volume":"11","author":"K Hoshi","year":"2021","unstructured":"Hoshi K, Ito H, Abe E, Fuwa TJ, Kanno M, Murakami Y, et al. Transferrin biosynthesized in the brain is a novel biomarker for Alzheimer\u2019s disease. Metabolites. 2021;11(9):616.","journal-title":"Metabolites"},{"issue":"9","key":"321_CR153","doi-asserted-by":"publisher","first-page":"6324","DOI":"10.1007\/s12035-019-1519-0","volume":"56","author":"TR Carden","year":"2019","unstructured":"Carden TR, Correale J, Pasquini JM, P\u00e9rez MJ. Transferrin enhances microglial phagocytic capacity. Mol Neurobiol. 2019;56(9):6324\u201340.","journal-title":"Mol Neurobiol"},{"issue":"2","key":"321_CR154","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.expneurol.2005.12.027","volume":"198","author":"A Adamo","year":"2006","unstructured":"Adamo A, Paez P, Cabrera OE, Wolfson M, Franco P, Pasquini J, et al. Remyelination after cuprizone-induced demyelination in the rat is stimulated by apotransferrin. Exp Neurol. 2006;198(2):519\u201329.","journal-title":"Exp Neurol"},{"issue":"4","key":"321_CR155","doi-asserted-by":"publisher","first-page":"109","DOI":"10.3390\/ph11040109","volume":"11","author":"MT Nu\u00f1ez","year":"2018","unstructured":"Nu\u00f1ez MT, Chana-Cuevas P. New perspectives in iron chelation therapy for the treatment of neurodegenerative diseases. Pharmaceuticals. 2018;11(4):109.","journal-title":"Pharmaceuticals"},{"issue":"9","key":"321_CR156","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1016\/S1474-4422(08)70167-4","volume":"7","author":"L Lannfelt","year":"2008","unstructured":"Lannfelt L, Blennow K, Zetterberg H, Batsman S, Ames D, Harrison J, et al. Safety, efficacy, and biomarker findings of PBT2 in targeting A\u03b2 as a modifying therapy for Alzheimer\u2019s disease: a phase IIa, double-blind, randomised, placebo-controlled trial. Lancet Neurol. 2008;7(9):779\u201386.","journal-title":"Lancet Neurol"},{"issue":"12","key":"321_CR157","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1001\/archneur.60.12.1685","volume":"60","author":"CW Ritchie","year":"2003","unstructured":"Ritchie CW, Bush AI, Mackinnon A, Macfarlane S, Mastwyk M, MacGregor L, et al. Metal-protein attenuation with iodochlorhydroxyquin (clioquinol) targeting A\u03b2 amyloid deposition and toxicity in Alzheimer disease: a pilot phase 2 clinical trial. Arch Neurol. 2003;60(12):1685\u201391.","journal-title":"Arch Neurol"},{"issue":"2\u20133","key":"321_CR158","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1159\/000338181","volume":"33","author":"Z Pernber","year":"2012","unstructured":"Pernber Z, Blennow K, Bogdanovic N, M\u00e5nsson JE, Blomqvist M. Altered distribution of the gangliosides GM1 and GM2 in Alzheimer\u2019s disease. Dement Geriatr Cogn Disord. 2012;33(2\u20133):174\u201388.","journal-title":"Dement Geriatr Cogn Disord"},{"issue":"1","key":"321_CR159","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13024-021-00488-7","volume":"16","author":"S Qiu","year":"2021","unstructured":"Qiu S, Palavicini JP, Wang J, Gonzalez NS, He S, Dustin E, et al. Adult-onset CNS myelin sulfatide deficiency is sufficient to cause Alzheimer\u2019s disease-like neuroinflammation and cognitive impairment. Mol Neurodegen. 2021;16(1):1\u201324.","journal-title":"Mol Neurodegen"},{"issue":"3","key":"321_CR160","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s10719-015-9579-5","volume":"32","author":"K Yanagisawa","year":"2015","unstructured":"Yanagisawa K. GM1 ganglioside and Alzheimer\u2019s disease. Glycoconj J. 2015;32(3):87\u201391.","journal-title":"Glycoconj J"}],"container-title":["Translational Neurodegeneration"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40035-022-00321-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40035-022-00321-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40035-022-00321-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,29]],"date-time":"2022-10-29T19:05:55Z","timestamp":1667070355000},"score":1,"resource":{"primary":{"URL":"https:\/\/translationalneurodegeneration.biomedcentral.com\/articles\/10.1186\/s40035-022-00321-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,26]]},"references-count":160,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["321"],"URL":"https:\/\/doi.org\/10.1186\/s40035-022-00321-1","relation":{},"ISSN":["2047-9158"],"issn-type":[{"value":"2047-9158","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,26]]},"assertion":[{"value":"17 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 October 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Dr. Saykin has received support from Avid Radiopharmaceuticals, a subsidiary of Eli Lilly (in kind contribution of PET tracer precursor); Bayer Oncology (Scientific Advisory Board); Eisai (Scientific Advisory Board); Siemens Medical Solutions USA, Inc. (Dementia Advisory Board); NIH NHLBI (MESA Observational Study Monitoring Board); Springer-Nature Publishing (Editorial Office Support as Editor-in-Chief, Brain Imaging and Behavior).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"47"}}